Member Info for graking

This has happened before some years ago and it took time to get back up. Not sure whats going on but we need a good RNS NOW.

Hopefully the price today is the harbinger of something big. Recent experience shows a rise like this is much lowered by the close of business Hope not but lets see.

Initwinit - on a promise then.

appears to now be the medicine of choice in reducing Covid effects and mortality rates by the UK medical profession. Its not only cheap but its side effects have been well known over many years of generic use. Intensive Care Units across the UK have been using it and the results have been dramatic when compared with the early days when ventilators were the main weapon . The key to its usage is it cheap price and availability for a struggling NHS. Can Synairgen treatment beat that, even if it shows a better outcome ?

to understand why this level of price drop over 2 days based on a minor legal case. The continuing failure to make a profit must have left many investors somewhat edgy and perhaps this is a straw on a camels back excuse for some. "Surprised" in one word.

chilting - not quite right. If I were to serve a legal notice on chilting plc at 3.00pm today, that is then in the public arena and HAS to be announced by the listed respondent without due delay.

A minor issue and the price will be back on track in the next day or two. This infringement claim is relatively trivial and appears to boil down to a minor component ie the flat pancake electric motor to be found in most automated distribution vehicles. If there is any breach, it is primarily by Printed Motor Works "PMW"(operating since 1963) but so happens that Ocado (and many others) are or have installed these motors may be equally liable only if mens rea can be established. If Ocado is not aware of a breach when contracting PMW then they have a huge defence and even if somehow deemed culpable (improbable), they would then themselves have a counter claim against PMW for any legal costs and resultant business costs.

And yet we constantly hear that the flu vaccine may not be the right one for this seasons anticipated strain.

Pressure drop.

Possibly insider trading

will pay to try a new promising medicine. Desperate Governments will watch very closely as the cohort rises, and inevitably followed by meaningful results, good or bad.

Has this been dropped ? Or only for those paying for the treatment which makes sense. And given that the plan is to flog thousands of the kits, who will be making them ? And then would those suffering badly with Covid 19 symptoms look for private care having been directed by their doc to A&E. And if duly directed, how are they going to find out about Synairgen unless an A&E Consultant tells them in which case he/she could administer the trial on me for free.. Granted they might get the damned useless placebo treatment via A&E but would they know better

And who wouldn't after this eyepopping 2 day drop

Will they ever publish better results followed by peer reviews. Insufficient data so far for peer reviews based on 79% of 50 patients. Trusting the MAP process does not hike prices to many £hundreds if not thousands per session. Not unrealistic if the following need to profit especially as they are trialling an unproven process though safe (safe as much as the developer says it is)
Synairgen
Clinigen
Private Clinic
Medical practitioner

Another opportunity for Ocado to sell its technology and offer a delivery service using its own or Aldi branded vans.

ProfitWaining - Do think it through -

I like to think that they have taken the Danegeld to top up their limited or non existent salaries until profits roll in. My hunch tells me that the forthcoming news is not too great. By now they know full well what the latest drilling results are and if it were good, would they not have deferred share sales till after that.

No doubt that private hospitals and medics will now be targeted. Not sure that in some European countries they are as ethical as we like to believe. Some will undoubtedly cry "success" because they have charged for it and others will remain silent. The marketing will rest on the 79% figure and who wouldn't buy it on the strength of that untested figure and pockets will be lined in the supply chain. Be nice to receive an update on how many Stage 3 trials are currently concluded and still underway. Suspect not enough, thus the sell out.

I so accept that Directors sometimes have to dispose of shares especially in smaller companies where income is limited until profits roll in. In a sense, they are taking the cash out of shareholders pockets. Be far better if Share options had to be BOUGHT at the start date price and available to sell in say 3 years at the then price (or keep them). Thats how staff share option schemes always work except Directors who are not required to buy at a pre determined date but are simply allocated them. Its whats known as elitist though makes sense only if they have forsaken any salary whist developing the company.

I wonder what they will be charging their private patients for this. Nothings free but clearly hospitals are not climbing over each other to trial it. And whats happened to overseas testing ? Nevertheless, a profitable company who are probably buying it to sell it.